CSJZX
Price
$55.09
Change
+$0.27 (+0.49%)
Updated
Sep 29, 6:59 PM EST
IVRSX
Price
$23.75
Change
+$0.01 (+0.04%)
Updated
Sep 29, 6:59 PM EST

Compare predictions CSJZX vs IVRSX

Header iconCSJZX vs IVRSX Comparison
Open Charts CSJZX vs IVRSXBanner chart's image
Cohen & Steers Realty Shares Z
Price$55.09
Change+$0.27 (+0.49%)
VolumeN/A
CapitalizationN/A
VY® CBRE Real Estate S
Price$23.75
Change+$0.01 (+0.04%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CSJZX vs IVRSX Comparison Chart

Loading...

VS
CSJZX vs. IVRSX commentary
Oct 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSJZX is a StrongSell and IVRSX is a StrongSell.

FUNDAMENTALS
Fundamentals
CSJZX has more cash in the bank: 5.34B vs. IVRSX (165M). CSJZX pays higher dividends than IVRSX: CSJZX (3.42) vs IVRSX (2.54). CSJZX was incepted earlier than IVRSX: CSJZX (4 years) vs IVRSX (35 years). IVRSX (1.26) is less costly to investors than CSJZX (0.83). IVRSX is a more actively managed with annual turnover of: 62.00 vs. CSJZX (32.00). CSJZX (0) and IVRSX (0) have matching initial minimum investment requirements. CSJZX annual gain was more profitable for investors over the last year : -1.59 vs. IVRSX (-4.58).
CSJZXIVRSXCSJZX / IVRSX
Total Expense Ratio0.800.9386%
Annual Report Gross Expense Ratio0.831.2666%
Fund Existence4 years35 years-
Gain YTD-3.704-9.48039%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.34B165M3,238%
Annual Yield % from dividends3.422.54134%
Returns for 1 year-1.59-4.5835%
Returns for 3 years5.79-8.58-67%
Returns for 5 yearsN/A-20.62-
Returns for 10 yearsN/A4.12-
View a ticker or compare two or three
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALA8.900.07
+0.79%
Kala BIO
SBSI28.70N/A
N/A
Southside Bancshares
ADNT36.70-0.04
-0.11%
Adient plc
FAST54.65-1.00
-1.80%
Fastenal Company
INFU9.64-0.20
-2.03%
InfuSystem Holdings